GSK and the Ebola vaccine: drug approval, ethics, corporate citizenship and regulatory strategy
Is the Ebola vaccine taking too long to get to market or is it being rushed too quickly? In spite of the World Health Organization (WHO) recommending that vaccines jump straight to phase III efficacy tests in Liberia, Guinea, and Sierra … Continued